A lipid profile study in polycystic ovary syndrome women
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20223500Keywords:
Polycystic ovaries syndrome, Lipid profile, BMI, HDL, LDL, VLDL, Cholesterol, TriglycerideAbstract
Background: Dyslipidemia in PCOS has multifactorial causation and insulin resistance plays a pivotal role by stimulation of lipolysis and altered lipases which are characterized by higher triglyceride and lower high-density lipoprotein cholesterol.1
Methods: This observational cross-sectional study was conducted in the obstetrics and gynaecology department of SPS hospital Ludhiana Punjab and included 60 women with PCOS and 30 non PCOS women of age group 18-40 who meet the inclusion criteria.
Results: PCOS women with BMI <18.5 (underweight) their mean cholesterol, HDL, LDL, VLDL and triglycerides were 158.00, 48.00, 74.00, 35.60, 178.00 respectively. PCOS women with BMI ranging from >18.5-24.99 (normal) the mean±SD for cholesterol, HDL, LDL, VLDL and triglycerides were 169.50 ± 21.83, 44.86±2.66, 85.80±20.33, 38.84±3.57, 194.18±17.86 respectively. PCOS Subjects with BMI25-29.99 (overweight) Mean±SD for total cholesterol was 197.04±18.16, HDL=40.48±3.19, LDL=112.37±18.10, VLDL=44.20±2.89 and for triglycerides was 221.00±14.45.
Conclusions: An early treatment for obesity should be a priority to prevent cardiometabolic complications in future in women with Polycystic ovaries syndrome.
Metrics
References
Lath R, Shendye R, Jibhkate A. Insulin resistance and lipid profile in polycystic ovary syndrome. Asian J Biomed Pharm Sci. 2015;5(48):30-5.
Cristian-Ioan I, Nicolae C, Dan M. Lipid parameters in patients with polycystic ovary syndrome. Appl Med Inform. 2012;31(4):27-32.
Kiranmayee D, Kavya K, Himabindu Y, Sriharibabu M, Madhuri GLJ, Venu S. Correlations between anthropometry and lipid profile in women with PCOS. J Hum Reprod Sci. 2017;10(3):167-72.
Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol Oxf. 2001;54(4):447-53.
Valkenburg O, Steegers-Theunissen RPM, Smedts HPM, Dallinga-Thie GM, Fauser BCJM, Westerveld EH, et al. A More atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: A case-control study. J Clin Endocrinol Metabol. 2007;93(2):470-6.
Berneis K, Rizzo M, Lazzaroni V, Fruzzetti F, Carmina E. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2007;92(1):186-9.
Macut D, Panidis D, Glick B, Spanos N, Petakov M, Beki J, et al. Lipid and lipoprotein profile in women with polycystic ovary syndrome. Can J Physiol Pharm. 2008;86(4):199-204.
Rocha MP, Marcondes JAM, Barcellos CRG, Hayashida SAY, Curi DDG, da Fonseca ÂM, et al. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecol Endocrinol. 2011;27(10):814-9.
Sudha A. Study of insulin resistance and lipid profile in polycystic ovarian syndrome. Int J Sci Res Publ. 2016;6(2):2250-3153.
Saghafi-Asl M, Pirouzpanah S, Ebrahimi-Mameghani M, Asghari-Jafarabadi M, Aliashrafi S, et al. Lipid profile in relation to anthropometric indices and insulin resistance in overweight women with polycystic ovary syndrome. Health Promot Perspect. 2013;3(2):206-16.
lae C, Dan M. Lipid parameters in patients with polycystic ovary syndrome. Appl Med Inform. 2012;31(4):27-32.
Kiranmayee D, Kavya K, Himabindu Y, Sriharibabu M, Madhuri GLJ, Venu S. Correlations between anthropometry and lipid profile in women with PCOS. J Hum Reprod Sci. 2017;10(3):167-72.
Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol (Oxf). 2001;54(4):447-53.
Valkenburg O, Steegers-Theunissen RPM, Smedts HPM, Dallinga-Thie G. M, Fauser BCJM, Westerveld EH, et al. A More atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: A case-control study. J Clin Endocrinol Metabol. 2007;93(2):470-6.
Berneis K, Rizzo M, Lazzaroni V, Fruzzetti F, Carmina E. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2007;92(1):186-89.
Macut D, Panidis D, Glick B, Spanos N, Petakov M., Beki J, Damjanovic S. Lipid and lipoprotein profile in women with polycystic ovary syndrome. Can J Physiol Pharm 2008:86(4):199–204.
Rocha M P, Marcondes J A M, Barcellos C R G, Hayashida S A Y, Curi D D G, da Fonseca  M, Baracat E. C. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecol Endocrinol. 2011;27(10):814-9.
Sudha A. Study of insulin resistance and lipid profile in polycystic ovarian syndrome. Int J Sci Res Publ. 2016;6(2):2250-3153.
Saghafi-Asl M, Pirouzpanah S, Ebrahimi-Mameghani M, Asghari-Jafarabadi M, Aliashrafi S, et al. Lipid profile in relation to anthropometric indices and insulin resistance in overweight women with polycystic ovary syndrome. Health Promot Perspect. 2013;3(2):206-16.
Downloads
Published
How to Cite
Issue
Section
